Poolbeg Pharma PLC Sustainability Reports
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company focused on developing innovative medicines and immunotherapies to address unmet medical needs. The company targets large addressable markets such as cancer immunotherapy-induced Cytokine Release Syndrome and metabolic conditions like obesity.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800UZ8WJLWYHBFL52
FIGI: BBG011J1D865
5 reports from 2021 to 2025
